Clinical EvidenceAmadeo2024-09-17T22:06:33+00:00 Clinical Evidence Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. February 28, 2024 Read More » Efficacy of probiotic in perennial allergic rhinitis under five year children: A randomized controlled trial. February 28, 2024 Read More » Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial. February 28, 2024 Read More » Treatment of perennial allergic rhinitis with lactic acid bacteria. February 28, 2024 Read More » The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. February 28, 2024 Read More » Use of streptococcus salivarius K12 in supporting the mucosal immune function of active young subjects: A randomized double-blind study. February 28, 2024 Read More » Preliminary data revealing efficacy of Streptococcus salivarius K12 in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: A multicenter study from the AIDA network PFAPA syndrome registry. February 28, 2024 Read More » Clinical effects of Streptococcus salivarius K12 in hospitalized COVID-19 patients: Results of a preliminary study. February 28, 2024 Read More » Possibilities of probiotic therapy in chronic inflammatory diseases of oropharynx. February 28, 2024 Read More » The effect of oral probiotics (streptococcus salivarius K12) on the salivary level of secretory immunoglobulin A, salivation rate, and oral biofilm: a pilot randomized clinical trial. February 28, 2024 Read More » Oropharyngeal probiotic ENT-K12 as an effective dietary intervention for children with recurrent respiratory tract infections during cold season. February 28, 2024 Read More » Ways to optimize the treatment of children with diseases of the respiratory tract and ENT organs. February 28, 2024 Read More » The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection. February 28, 2024 Read More » Oropharyngeal probiotic ENT-K12 prevents respiratory tract infections among frontline medical staff fighting against COVID-19: A pilot study. February 28, 2024 Read More » Experience with the use of oral probiotic streptococcus salivarius K12 for the prevention of recurrence of pharyngotonsillar episodes. February 28, 2024 Read More » Efficacy of administering Streptococcus salivarius K12 as a powder formula in preventing respiratory infections in infants. February 28, 2024 Read More » An open-label study to evaluate the effects of Streptococcus salivarius K12 given as a powder formula to prevent respiratory infections in young children. February 28, 2024 Read More » The efficiency of respiratory probiotic Streptococcus salivarius K12 use in children with recurrent tonsillitis. February 28, 2024 Read More » Application of Streptococcus salivarius K12 probiotic strain in the treatment of acute tonsillopharyngitis in children. February 28, 2024 Read More » Impact of Streptococcus salivarius K12 on nasopharyngeal and saliva microbiome: a randomized controlled trial. February 28, 2024 Read More » Load More
Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. February 28, 2024 Read More »
Efficacy of probiotic in perennial allergic rhinitis under five year children: A randomized controlled trial. February 28, 2024 Read More »
Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial. February 28, 2024 Read More »
The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. February 28, 2024 Read More »
Use of streptococcus salivarius K12 in supporting the mucosal immune function of active young subjects: A randomized double-blind study. February 28, 2024 Read More »
Preliminary data revealing efficacy of Streptococcus salivarius K12 in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: A multicenter study from the AIDA network PFAPA syndrome registry. February 28, 2024 Read More »
Clinical effects of Streptococcus salivarius K12 in hospitalized COVID-19 patients: Results of a preliminary study. February 28, 2024 Read More »
Possibilities of probiotic therapy in chronic inflammatory diseases of oropharynx. February 28, 2024 Read More »
The effect of oral probiotics (streptococcus salivarius K12) on the salivary level of secretory immunoglobulin A, salivation rate, and oral biofilm: a pilot randomized clinical trial. February 28, 2024 Read More »
Oropharyngeal probiotic ENT-K12 as an effective dietary intervention for children with recurrent respiratory tract infections during cold season. February 28, 2024 Read More »
Ways to optimize the treatment of children with diseases of the respiratory tract and ENT organs. February 28, 2024 Read More »
The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection. February 28, 2024 Read More »
Oropharyngeal probiotic ENT-K12 prevents respiratory tract infections among frontline medical staff fighting against COVID-19: A pilot study. February 28, 2024 Read More »
Experience with the use of oral probiotic streptococcus salivarius K12 for the prevention of recurrence of pharyngotonsillar episodes. February 28, 2024 Read More »
Efficacy of administering Streptococcus salivarius K12 as a powder formula in preventing respiratory infections in infants. February 28, 2024 Read More »
An open-label study to evaluate the effects of Streptococcus salivarius K12 given as a powder formula to prevent respiratory infections in young children. February 28, 2024 Read More »
The efficiency of respiratory probiotic Streptococcus salivarius K12 use in children with recurrent tonsillitis. February 28, 2024 Read More »
Application of Streptococcus salivarius K12 probiotic strain in the treatment of acute tonsillopharyngitis in children. February 28, 2024 Read More »
Impact of Streptococcus salivarius K12 on nasopharyngeal and saliva microbiome: a randomized controlled trial. February 28, 2024 Read More »
